Hypofractionation is ‘Excellent Tool’ in Radiotherapy for Lung Cancer
FDA Issues Partial Clinical Hold on Lorigerlimab Trial in Gynecologic Cancers: The FDA has suspended the Lorigerlimab trial in gynecologic cancers due to safety concerns, which include severe safety incidents that were previously reported.
Refining Management of Immune-Checkpoint Inhibitor Toxicities in Melanoma: Progress has been made in the management of melanoma, particularly with the use of immune-checkpoint inhibitor toxicities.
FDA Grants Fast Track Designation to SRN-101 for Recurrent High-Grade Glioma: The FDA has granted fast track designation to SRN-101 for recurrent high-grade glioma, highlighting the importance of rapid development and review of drugs that treat serious conditions.
Novel Small Molecule Shows Early Activity in Pretreated Multiple Myeloma: A breakthrough small molecule is showing promising early results in the treatment of multiple myeloma.
Comparing Quality of Life Outcomes with Protons vs Photons in OPSCC: Quality of life outcomes in cases of oropharyngeal cancer (OPSCC) are being compared, focusing on the impact of protons versus photons treatment regimens.
